We bring you the latest news from the healthcare about the health care in the United Kingdom.

vrijdag 6 juli 2018

Oncogene - Table of Contents alert Volume 37 Issue 27

If you are unable to see the message below, click here to view.
Oncogene

Advertisement
FCS2018 is jointly organized by six major research institutes in Singapore and includes an impressive line-up of speakers including two Nobel Laureates. Converging the latest cancer discoveries around the world, and the meeting promises ground-breaking and innovative insights into cancer research. 

REGISTER NOW to secure your chance to interact and learn from the experts!

TABLE OF CONTENTS

Volume 37, Issue 27

In this issue
Article
Brief Communications
Also new
AOP

Article

CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis

Qinglian Tang, Jinchang Lu, Changye Zou, Yang Shao, Yan Chen et al.

Oncogene 2018 37 :3617 - 3630; April 03, 2018; 10.1038/s41388-018-0231-2

Abstract | Full Text

cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage

María Castejón-Griñán, Cecilia Herraiz, Conchi Olivares, Celia Jiménez-Cervantes & Jose Carlos García-Borrón

Oncogene 2018 37 :3631 - 3646; April 06, 2018; 10.1038/s41388-018-0216-1

Abstract | Full Text

NFκB regulates p21 expression and controls DNA damage-induced leukemic differentiation

Claudia M. Nicolae, Michael J. O'Connor, Daniel Constantin & George-Lucian Moldovan

Oncogene 2018 37 :3647 - 3656; April 06, 2018; 10.1038/s41388-018-0219-y

Abstract | Full Text

RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines

Francesca Pentimalli, Iris M. Forte, Luca Esposito, Paola Indovina, Carmelina A. Iannuzzi et al.

Oncogene 2018 37 :3657 - 3671; April 02, 2018; 10.1038/s41388-018-0214-3

Abstract | Full Text

Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer

Jenna H. Newman, David J. Augeri, Rachel NeMoyer, Jyoti Malhotra, Elaine Langenfeld et al.

Oncogene 2018 37 :3672 - 3685; April 06, 2018; 10.1038/s41388-018-0156-9

Abstract | Full Text

Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models

Denise L. Crossland, Warren L. Denning, Sonny Ang, Simon Olivares, Tiejuan Mi et al.

Oncogene 2018 37 :3686 - 3697; April 06, 2018; 10.1038/s41388-018-0187-2

Abstract | Full Text

Rab34 regulates adhesion, migration, and invasion of breast cancer cells

Lixiang Sun, Xiaohui Xu, Yongjun Chen, Yuxia Zhou, Ran Tan et al.

Oncogene 2018 37 :3698 - 3714; April 06, 2018; 10.1038/s41388-018-0202-7

Abstract | Full Text

Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3ß and F-box and WD repeat domain-containing 7

Ji Hoon Jung, Deok-Beom Jung, Hyunseok Kim, Hyemin Lee, Shi-Eun Kang et al.

Oncogene 2018 37 :3715 - 3728; April 09, 2018; 10.1038/s41388-018-0225-0

Abstract | Full Text

ΔNp73 enhances HIF-1α protein stability through repression of the ECV complex

Marina Stantic, Johanna Wolfsberger, Habib A. M. Sakil & Margareta T. Wilhelm

Oncogene 2018 37 :3729 - 3739; April 09, 2018; 10.1038/s41388-018-0195-2

Abstract | Full Text

A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

Ismail Labgaa, Carlos Villacorta-Martin, Delia D'Avola, Amanda J. Craig, Johann von Felden et al.

Oncogene 2018 37 :3740 - 3752; April 09, 2018; 10.1038/s41388-018-0206-3

Abstract | Full Text

Brief Communications

WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma

Dario Zimmerli, Virginia Cecconi, Tomas Valenta, George Hausmann, Claudio Cantù et al.

Oncogene 2018 37 :3753 - 3762; April 17, 2018; 10.1038/s41388-018-0244-x

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature